-
CHARACTERIZATION OF PATIENTS WITH PROSTATE CANCER IN COLOMBIA FROM A REAL-WORLD MULTICENTER FROM A HEALTHCARE RESOURCE UTILIZATION (HRU) STUDY
Feb 25, 2026, 14:41 PM -
ANTIHYPERTENSIVE TREATMENT PATTERNS BEFORE AND DURING PREGNANCY AMONG WOMEN WITH CHRONIC HYPERTENSION: A REAL-WORLD EHR STUDY
Feb 25, 2026, 14:41 PM -
FAMILY IMPACT OF ADULT ANGELMAN SYNDROME: CAREGIVER PERSPECTIVES
Feb 25, 2026, 14:41 PM -
COMPARISON OF BENEFIT DESIGN FOR DIABETES MEDICATIONS BETWEEN CONVENTIONAL MEDICARE ADVANTAGE PLANS AND CHRONIC CONDITION SPECIAL NEEDS PLANS
Feb 25, 2026, 14:41 PM -
COVERAGE COMPLETENESS AND TREATMENT COST ESTIMATION FOR ADMINISTERED DRUGS IN US COMMERCIAL PAYER PRICE TRANSPARENCY DATA
Feb 25, 2026, 14:41 PM -
IMPACT OF GOVERNMENT REIMBURSEMENT NEGOTIATION ON THE ECONOMIC BURDEN OF RARE DISEASE IN CHINA: A CONTROLLED INTERRUPTED TIME SERIES ANALYSIS
Feb 25, 2026, 14:41 PM -
REAL-WORLD EFFECTIVENESS OF STATIN THERAPY AND PREDICTIVE MODELING OF ADHERENCE AMONG PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
Feb 25, 2026, 14:41 PM -
CROSS-SECTIONAL REAL-WORLD EVALUATION OF GLYCEMIC CONTROL, HYPERTENSION, LIFESTYLE FACTORS, AND DRUG UTILIZATION PATTERNS AMONG 500 PATIENTS WITH TYPE 2 DIABETES MELLITUS IN INDIA
Feb 25, 2026, 14:41 PM -
REAL-WORLD DATA IN ORPHAN DRUG APPROVALS: A COMPARATIVE ANALYSIS OF THE UNITED STATES, CHINA, AND JAPAN
Feb 25, 2026, 14:41 PM -
THE FALSE CONFIDENCE OF UNANCHORED MAIC: LESSONS IN ULCERATIVE COLITIS
Feb 25, 2026, 14:41 PM -
INFORMAL MOBILE PHONE USE AS A DE-FACTO DIGITAL INFRASTRUCTURE IN DISEASE CONTROL: REAL-WORLD EVIDENCE FROM FRONTLINE HEALTH WORKERS IN ENUGU STATE, NIGERIA
Feb 25, 2026, 14:41 PM -
INFORMING OVERALL SURVIVAL EXTRAPOLATION IN HEALTH TECHNOLOGY ASSESSMENT USING STRUCTURED EXPERT ELICITATION: A NICE TSD 26 CASE STUDY
Feb 25, 2026, 14:41 PM -
ACCESS TO HEALTHCARE, UTILIZATION, AND EXPENDITURES AMONG ADULTS WITH DIABETES AND CARDIORENAL COMORBIDITIES
Feb 25, 2026, 14:41 PM -
EVIDENCE GENERATION MEETS DATA SCIENCE: A TAXONOMY-BASED EVIDENCE MAP OF AI-FOCUSED ISPOR 2025 ABSTRACTS
Feb 25, 2026, 14:41 PM -
PREPARING FOR THE NEXT ACCESS PARADIGM: TRANSITIONING FROM A REBATE-DOMINANT MARKET TO EU-STYLE EVIDENCE-BASED VALUE TO MAXIMIZE US PAYER COVERAGE
Feb 25, 2026, 14:41 PM -
COMPARATIVE EFFECTIVENESS OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING METHODS VERSUS TRADITIONAL DISPROPORTIONALITY ANALYSIS FOR ADVERSE DRUG REACTION SIGNAL DETECTION: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:41 PM -
INTERNATIONAL REFERENCE PRICING CAPS ARE HIGHLY DESIGN-SENSITIVE: CAP-SETTING COUNTRIES AND ACCESS SIGNALS FOR INCRETIN THERAPIES
Feb 25, 2026, 14:41 PM -
PREDICTING FERTILITY INTENTIONS USING SOCIODEMOGRAPHIC AND REPRODUCTIVE FACTORS IN THE UNITED STATES: A MACHINE LEARNING APPROACH
Feb 25, 2026, 14:41 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Feb 25, 2026, 14:41 PM -
COST-SAVINGS ASSOCIATED WITH VENETOCLAX-OBINUTUZUMAB VERSUS COVALENT BRUTON’S TYROSINE KINASE INHIBITOR IN FRONTLINE CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY
Feb 25, 2026, 14:41 PM
